Advanced in Peripheral T-Cell Lymphoma

Hang W. Su

600 South Wanping Road, 
Shanghai, CN 
Advanced in Peripheral T-Cell Lymphoma
600 South Wanping Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Hang Su practices in Shanghai, China. Ms. Su is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Peripheral T-Cell Lymphoma, Osteotomy, and Endoscopy.

Her clinical research consists of co-authoring 709 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Peripheral T-Cell Lymphoma.

Gender
Female

Locations

600 South Wanping Road, Shanghai, 200030, China
Other Locations
No. 16 Xinhuaxi Road, Cangzhou, 061000, China
600 Yishan Road, Shanghai, 200233, China
China Japan Union Hospital of Jilin University
Changchun, 130033, China
Jinshui East Road 156, Zhengzhou, 450046, China
600 Wan Ping Nan Road, Shanghai, China
Chinese Academy Of Medical Science And Peking Union Medical College, Beijing, 100021, China
457 Zhongshan Road, Dalian, 116023, China
No.156 Jinshui East Road, Zhengzhou, China
No.8 Fengtai East Street, Fengtai, 100071, China
1380, West Zhong Shan Road, Zhongshan, 200336, China
Wenhua Road 103, Shenyang, 110016, China
301 Middle Yanchang Road, Shanghai, 200072, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)
A Phase 2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2025
Intervention Type: Drug
Study Drug: LOXO-305
Study Phase: Phase 2
A Phase II, Multicenter, Open, Single-arm Study of TQB2450 Injection (PD-L1 Antibody) in Subjects With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)
A Phase II, Multicenter, Open, Single-arm Study of TQB2450 Injection (PD-L1 Antibody) in Subjects With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)
Enrollment Status: Terminated
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

709 Total Publications

A high-capacity and stable rate-performance Li-ion battery anode based on hierarchical microcakes with in situ grown nanoflakes.
A high-capacity and stable rate-performance Li-ion battery anode based on hierarchical microcakes with in situ grown nanoflakes.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Su's expertise for a condition
ConditionClose
    View All 102 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile